{"id":164419,"date":"2022-12-24T00:13:10","date_gmt":"2022-12-24T05:13:10","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/applied-molecular-transport-announces-top-line-phase-2-results-from-lombard-monotherapy-trial-of-oral-amt-101-in-patients-with-moderate-to-severe\/"},"modified":"2024-08-18T11:46:41","modified_gmt":"2024-08-18T15:46:41","slug":"applied-molecular-transport-announces-top-line-phase-2-results-from-lombard-monotherapy-trial-of-oral-amt-101-in-patients-with-moderate-to-severe","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/applied-molecular-transport-announces-top-line-phase-2-results-from-lombard-monotherapy-trial-of-oral-amt-101-in-patients-with-moderate-to-severe.php","title":{"rendered":"Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe&#8230;"},"content":{"rendered":"<p><![CDATA[\u2013 Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12]]><\/p>\n<p>View original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/12\/22\/2578946\/0\/en\/Applied-Molecular-Transport-Announces-Top-line-Phase-2-Results-from-LOMBARD-Monotherapy-Trial-of-Oral-AMT-101-in-Patients-with-Moderate-to-Severe-Ulcerative-Colitis.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe...\">Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View original post here: Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/applied-molecular-transport-announces-top-line-phase-2-results-from-lombard-monotherapy-trial-of-oral-amt-101-in-patients-with-moderate-to-severe.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-164419","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164419"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=164419"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=164419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=164419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=164419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}